| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Articles: Hormones and Reproductive Health |
Department of Psychiatry, Weill Medical College, Cornell University (M.A., C.R.), New York, New York 10021; Behavioral Endocrinology Branch, National Institute of Mental Health, National Institutes of Health (C.R.), Bethesda, Maryland 20892; and Department of Military and Emergency Medicine, Uniformed Services University of the Health Sciences (E.G., P.D.), Bethesda, Maryland 20814
Address all correspondence and requests for reprints to: Dr. Margaret Altemus, Box 244, Weill Medical College, Cornell University, 1300 York Avenue, New York, New York 10021. E-mail: maltemus{at}mail.med
Abstract
Accumulating evidence indicates that gonadal steroids modulate functioning of the hypothalamic-pituitary-adrenal (HPA) axis, which has been closely linked to the pathophysiology of anxiety and depression. However, the effect of the natural menstrual cycle on HPA axis responsivity to stress has not been clearly described. In nine healthy women, metabolic and hormonal responses to treadmill exercise stress during the early follicular phase of the menstrual cycle, when gonadal steroid levels are low, were compared with responses in the midluteal phase of the cycle, when both progesterone and estrogen levels are relatively high. Exercise intensity was gradually increased over 20 min to reach 90% of each subjects maximal oxygen consumption during the final 5 min of exercise. Basal plasma lactate, glucose, ACTH, vasopressin, oxytocin, and cortisol levels were similar in the two cycle phases. However, in response to exercise stress, women in the midluteal phase had enhanced ACTH (P < 0.0001), vasopressin (P < 0.01), and glucose (P < 0.001) secretion. These findings suggest that relatively low levels of gonadal steroids during the early follicular phase of the menstrual cycle provide protection from the impact of stress on the HPA axis.
This article has been cited by other articles:
![]() |
M. Bloch, D. R. Rubinow, P. J. Schmidt, A. Lotsikas, G. P. Chrousos, and G. Cizza Cortisol Response to Ovine Corticotropin-Releasing Hormone in a Model of Pregnancy and Parturition in Euthymic Women with and without a History of Postpartum Depression J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 695 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. YOUNG and M. ALTEMUS Puberty, Ovarian Steroids, and Stress Ann. N.Y. Acad. Sci., June 1, 2004; 1021(1): 124 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhao and R. D. Brinton Suppression of Proinflammatory Cytokines Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} in Astrocytes by a V1 Vasopressin Receptor Agonist: A cAMP Response Element-Binding Protein-Dependent Mechanism J. Neurosci., March 3, 2004; 24(9): 2226 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Roca, P. J. Schmidt, M. Altemus, P. Deuster, M. A. Danaceau, K. Putnam, and D. R. Rubinow Differential Menstrual Cycle Regulation of Hypothalamic-Pituitary-Adrenal Axis in Women with Premenstrual Syndrome and Controls J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3057 - 3063. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |